Literature DB >> 17487508

Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum.

Humphrey N Ehigiator1, Pablo Romagnoli, Jeffrey W Priest, W Evan Secor, Jan R Mead.   

Abstract

Cp23 has been identified as one of the immunodominant antigens involved in the immune response to Cryptosporidium parvum infection. Thus, in this study, Cp23 antigen was investigated as a vaccine candidate using the DNA vaccine model in adult interleukin-12 (IL-12) knockout (KO) mice, which are susceptible to C. parvum infection. Our data show that subcutaneous immunization in the ear with DNA encoding Cp23 (Cp23-DNA) cloned into the pUMVCb4 vector induced a significant anti-Cp23 immunoglobulin G1 (IgG1) and IgG2a antibody response and specific in vitro spleen cell proliferation to recombinant Cp23 as compared to control mice. Long-term memory responses were also detected after administration of the Cp23-DNA vaccine. Furthermore, Cp23-DNA vaccination induced a 50-60% reduction in oocysts shedding, indicating a partial protection against C. parvum infection in IL-12 KO mice. However, it is possible that this protective response was nonspecific because mice immunized with vector only also exhibited lower oocyst shedding than the naive controls. These results suggest that DNA encoding for immunodominant C. parvum antigens may provide an effective means of eliciting humoral and cellular responses and possibly in generating protective immunity against C. parvum infections in mammals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487508     DOI: 10.1007/s00436-007-0565-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  43 in total

1.  Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test.

Authors:  He Hong-Xuan; Chen Lei; Wang Cheng-Min; Zhou Kai; Tang Yi; Qin Xi-Ming; Duan Ming-Xing
Journal:  J Nanosci Nanotechnol       Date:  2005-08

2.  Diarrhea, CD4+ cell counts and opportunistic protozoa in Indian HIV-infected patients.

Authors:  Javid Sadraei; Moshahid A Rizvi; U K Baveja
Journal:  Parasitol Res       Date:  2005-07-07       Impact factor: 2.289

3.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes.

Authors:  L E Perryman; D P Jasmer; M W Riggs; S G Bohnet; T C McGuire; M J Arrowood
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

4.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

Authors:  L E Perryman; S J Kapil; M L Jones; E L Hunt
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

5.  Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice.

Authors:  Ana M Espino; Antonio Osuna; Ramón Gil; George V Hillyer
Journal:  Exp Parasitol       Date:  2005-08       Impact factor: 2.011

6.  Modulation of B-cell proliferative response by a soluble extract of Nippostrongylus brasiliensis.

Authors:  H N Ehigiator; A W Stadnyk; T D Lee
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12.

Authors:  Yinchang Zhu; Jiangong Ren; Akram Da'dara; Donald Harn; Ming Xu; Jin Si; Chuanxin Yu; Yousheng Liang; Ping Ye; Xuren Yin; Wei He; Yongliang Xu; Guoqun Cao; Wanquan Hua
Journal:  Vaccine       Date:  2004-11-15       Impact factor: 3.641

8.  Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans.

Authors:  J R Mead; M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1988-02       Impact factor: 1.276

9.  Detection of antibodies to a recombinant Cryptosporidium parvum p23 in serum and feces from neonatal calves.

Authors:  Hsu-Fong Wang; John B Swain; Thomas E Besser; Douglas Jasmer; Carol R Wyatt
Journal:  J Parasitol       Date:  2003-10       Impact factor: 1.276

10.  DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.

Authors:  Alp E Oran; Harriet L Robinson
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  15 in total

1.  Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.

Authors:  Alvaro Benitez; Jeffrey W Priest; Humphrey N Ehigiator; Nina McNair; Jan R Mead
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

2.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

3.  Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species.

Authors:  Patricio A Manque; Fernando Tenjo; Ute Woehlbier; Ana M Lara; Myrna G Serrano; Ping Xu; João M Alves; Ronald B Smeltz; Daniel H Conrad; Gregory A Buck
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

Review 4.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

5.  Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.

Authors:  Zahra Omidian; Elahe Ebrahimzadeh; Parisa Shahbazi; Zeinab Asghari; Parviz Shayan
Journal:  Parasitol Res       Date:  2013-10-24       Impact factor: 2.289

6.  Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice.

Authors:  Rihua Xu; Honglin Jia; Mohamad Alaa Terkawi; Xuenan Xuan; Heping Zhang
Journal:  Curr Microbiol       Date:  2011-02-20       Impact factor: 2.188

7.  Asparagine-Linked Glycans of Cryptosporidium parvum Contain a Single Long Arm, Are Barely Processed in the Endoplasmic Reticulum (ER) or Golgi, and Show a Strong Bias for Sites with Threonine.

Authors:  John R Haserick; Deborah R Leon; John Samuelson; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

8.  Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice.

Authors:  Alvaro J Benitez; Nina McNair; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

9.  Cryptosporidium parvum has an active hypusine biosynthesis pathway.

Authors:  Nimisha Mittal; Marie Morada; Pankaj Tripathi; V S Gowri; Swati Mandal; Alison Quirch; Myung Hee Park; Nigel Yarlett; Rentala Madhubala
Journal:  Mol Biochem Parasitol       Date:  2014-06-02       Impact factor: 1.759

10.  Cryptosporidiosis-an overview.

Authors:  Gordon J Leitch; Qing He
Journal:  J Biomed Res       Date:  2012-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.